| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.25 | 0.02 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |